Marimed (MRMD) Price to Book (2012 - 2026)

Marimed (MRMD) has reported Price to Book for 15 consecutive years, with 0.65 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 34.74% year-over-year to 0.65 in Q2 2026; TTM through Jun 2026 was 0.65, a 34.74% increase from a year earlier, with the FY2025 full-year figure at 0.71, down 8.64% from the prior year.
• Price to Book was 0.65 for Q2 2026 at Marimed, up from 0.6 in the prior quarter.
• Over five years, Price to Book peaked at 5.62 in Q1 2022 and troughed at 0.48 in Q2 2025.
• A 5-year average of 1.62 and a median of 1.27 in 2024 frame the typical range for Price to Book.
• The widest YoY moves for Price to Book: up 388.91% in 2022, down 73.21% in 2022.
• Over 5 years, Price to Book stood at 2.15 in 2022, then dropped by 28.92% to 1.52 in 2023, then sank by 48.72% to 0.78 in 2024, then retreated by 8.64% to 0.71 in 2025, then slipped by 9.09% to 0.65 in 2026.
• The last three Price to Book figures came in at 0.65 (Q2 2026), 0.6 (Q1 2026), and 0.71 (Q4 2025), per Business Quant data.